Cisapride monohydrateProduct ingredient for Cisapride
- Name
- Cisapride monohydrate
- Drug Entry
- Cisapride
In many countries (including Canada) cisapride has been either withdrawn or has had its indications limited due to reports about long QT syndrome due to cisapride, which predisposes to arrhythmias. The FDA issued a warning letter regarding this risk to health care professionals and patients.
- Accession Number
- DBSALT001018
- Structure
Structure for Cisapride monohydrate (DBSALT001018)
- Synonyms
- Not Available